Sort   by:  
 Page size 
UnknownAssociation analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Not available
S-EPMC6568012 | biostudies-literature
UnknownCohort Profile: The Ovarian Cancer Cohort Consortium (OC3).
Not available
S-EPMC9425513 | biostudies-literature
UnknownOvarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium.
Not available
S-EPMC6488363 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownCirculating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study.
Not available
S-EPMC6746173 | biostudies-literature
UnknownLarge-scale transcriptome-wide association study identifies new prostate cancer risk regions.
Not available
S-EPMC6172280 | biostudies-literature
UnknownAssessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Not available
S-EPMC9049976 | biostudies-literature
UnknownGenome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.
Not available
S-EPMC5711884 | biostudies-literature
UnknownAn integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.
Not available
S-EPMC7413371 | biostudies-literature
Sort   by:  
 Page size